[{"Assets_0_Q1_USD":12854800000.0,"CIK":"872589","Country":"United States","EarningsPerShareBasic_1_Q1_USD":4.23,"EarningsPerShareDiluted_1_Q1_USD":3.99,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"77738004554.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":897000000.0,"NetIncomeLossConverted_1_Q1_USD":461100000.0,"OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","RevenuesConverted_1_Q1_USD":1711800000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquity_0_Q1_USD":9444700000.0,"Ticker":"REGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":115500000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":108900000.0,"filed":"20190507","footnote":"nan","form":"10-Q","fp":"Q1","fy":"2019.0","name":"REGENERON PHARMACEUTICALS INC","period":"20190331","qtrs":"0","uom":"USD"}]